Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bromocriptine in the treatment of acromegaly.
Bateman DE, Tunbridge WM. Bateman DE, et al. Among authors: tunbridge wm. Drugs. 1979 May;17(5):359-64. doi: 10.2165/00003495-197917050-00005. Drugs. 1979. PMID: 378651 Review. No abstract available.
Proceedings: Bromocriptine therapy of acromegaly.
Gomez-Pan A, Sachdev Y, Duns A, Tunbridge WM, Hall R. Gomez-Pan A, et al. Among authors: tunbridge wm. J Endocrinol. 1975 Nov;67(2):68P. J Endocrinol. 1975. PMID: 1206318 No abstract available.
Bromocriptine therapy in acromegaly.
Sachdev Y, Gomez-Pan A, Tunbridge WM, Duns A, Weightman DR, Hall R, Goolamali SK. Sachdev Y, et al. Among authors: tunbridge wm. Lancet. 1975 Dec 13;2(7946):1164-8. doi: 10.1016/s0140-6736(75)92655-0. Lancet. 1975. PMID: 53655 Clinical Trial.
Hypothalamic hormone interaction in acromegaly.
Gomez-Pan A, Tunbridge WM, Duns A, Hall R, Besser GM, Coy DH, Schally AV, Kastin AJ. Gomez-Pan A, et al. Among authors: tunbridge wm. Clin Endocrinol (Oxf). 1975 Sep;4(5):455-60. doi: 10.1111/j.1365-2265.1975.tb01554.x. Clin Endocrinol (Oxf). 1975. PMID: 170027
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.
Hall R, Besser GM, Schally AV, Coy DH, Evered D, Goldie DJ, Kastin AJ, McNeilly AS, Mortimer CH, Phenekos C, Tunbridge WM, Weightman D. Hall R, et al. Among authors: tunbridge wm. Lancet. 1973 Sep 15;2(7829):581-4. doi: 10.1016/s0140-6736(73)92413-6. Lancet. 1973. PMID: 4125377 Clinical Trial. No abstract available.
Letter: Analogues of growth-hormone release-inhibiting hormone.
Evered DC, Gomez-Pan A, Tunbridge WM, Hall R, Lind T, Besser GM, Mortimer CH, Thorner MO, Schally AV, Kastin AJ, Coy DH. Evered DC, et al. Among authors: tunbridge wm. Lancet. 1975 May 31;1(7918):1250. doi: 10.1016/s0140-6736(75)92248-5. Lancet. 1975. PMID: 48882 No abstract available.
Technical aspects of the radioimmunoassay of thyrotrophin.
Tunbridge WM, Petersen VB, Weightman DR. Tunbridge WM, et al. J Clin Pathol. 1975 Mar;28(3):231-3. doi: 10.1136/jcp.28.3.231. J Clin Pathol. 1975. PMID: 1123451 Free PMC article. No abstract available.
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients.
Mortimer CH, Tunbridge WM, Carr D, Yeomans L, Lind T, Coy DH, Bloom SR, Kastin A, Mallinson CN, Besser GM, Schally AV, Hall R. Mortimer CH, et al. Among authors: tunbridge wm. Lancet. 1974 Apr 20;1(7860):697-701. doi: 10.1016/s0140-6736(74)92903-1. Lancet. 1974. PMID: 4132421 No abstract available.
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination.
Mortimer CH, Besser GM, McNeilly AS, Tunbridge WM, Gomez-Pan A, Hall R. Mortimer CH, et al. Among authors: tunbridge wm. Clin Endocrinol (Oxf). 1973 Oct;2(4):317-26. doi: 10.1111/j.1365-2265.1973.tb01717.x. Clin Endocrinol (Oxf). 1973. PMID: 4358345 No abstract available.
60 results